Igal Ifergan

6PUBLICATIONS
9CO-AUTHORS
AutoimmunityInnate immunityNeurology and neuromuscular diseasesHealth and ecological risk assessmentApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 07, 2026
Poly(lactic-co-glycolic acid) immunomodulatory nanoparticles attenuate neuroinflammation and Alzheimer's disease-related pathology in 5xFAD mice.

|Apr 27, 2026
Canonical WNT Ligands Produced by Regulatory T Cells Restrain Effector CD4+ T Cell Responses.

|Feb 09, 2026
Dual Role of Ninjurin-1 in Myeloid Cell Adhesion and Inflammation in Relapse-Remitting EAE.

Coleen Thompson, Alex Annett, Anastasia Alkhimovitch

|Jun 13, 2025
Structural insights into the activation and inhibition of the ADAM17-iRhom2 complex.

Joseph J Maciag, Conner E Slone, Hala F Alnajjar

|Mar 03, 2025
Wnt-Activated Immunoregulatory Myeloid Cells Prevent Relapse in Experimental Autoimmune Encephalomyelitis and Offer a Potential Therapeutic Strategy for Multiple Sclerosis.

Anastasia Alkhimovitch, Stephen D Miller, Igal Ifergan

|Dec 24, 2021
Tolerance Induced by Antigen-Loaded PLG Nanoparticles Affects the Phenotype and Trafficking of Transgenic CD4+ and CD8+ T Cells.

Tobias Neef, Igal Ifergan, Sara Beddow

Pageof 1

Frequent Collaborators

2 joint publications

Anastasia Alkhimovitch

2 joint publications

Kashish Singh Parihar

1 joint publications

Stephen D Miller

1 joint publications

Joseph J Maciag